Paul Sugarbaker

Q: What Schools Are Affiliated With Paul Sugarbaker

Paul Sugarbaker is affiliated with the following schools: University of New South Wales, University of Michigan, Cornell University

Paul Sugarbaker's AcademicInfluence.com Rankings

Paul Sugarbaker

Philosophy

#2138

World Rank

#3716

Historical Rank

#798

USA Rank

Logic

#455

World Rank

#854

Historical Rank

#181

USA Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Paul Sugarbaker Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Paul Hendrick Sugarbaker is an American surgeon at the Washington Cancer Institute. He is known for developments in surgical oncology of the abdomen, including cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy, or HIPEC, a treatment alternately referred to as the Sugarbaker Procedure.

(See a Problem?)

Paul Sugarbaker's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. (1996) (1278)
The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. (1982) (1188)
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. (2004) (1117)
Peritonectomy Procedures (1995) (899)
Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. (2012) (808)
Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". (1995) (768)
Results of Treatment of 385 Patients With Peritoneal Surface Spread of Appendiceal Malignancy (1999) (601)
New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? (2006) (577)
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. (2009) (554)
Prognostic Features of 51 Colorectal and 130 Appendiceal Cancer Patients with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy (1995) (551)
A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. (1987) (537)
Resection of the liver for colorectal carcinoma metastases (1988) (509)
A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process (2016) (443)
Morbidity and Mortality Analysis of 200 Treatments With Cytoreductive Surgery and Hyperthermic Intraoperative Intraperitoneal Chemotherapy Using the Coliseum Technique (1999) (397)
Peritonectomy procedures. (1996) (395)
Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. (1998) (370)
Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis (2001) (365)
Quality of life assessment of patients in extremity sarcoma clinical trials. (1982) (339)
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement (2006) (339)
A Systematic Review and Meta-analysis of the Randomized Controlled Trials on Adjuvant Intraperitoneal Chemotherapy for Resectable Gastric Cancer (2007) (334)
Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. (2006) (330)
Successful management of microscopic residual disease in large bowel cancer (1999) (312)
A Systematic Review on the Efficacy of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei (2007) (287)
Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. (2006) (286)
Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer (2005) (283)
Management of peritoneal-surface malignancy: the surgeon’s role (1999) (271)
Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding (2004) (267)
Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. (1995) (261)
Evaluation of computed tomography in patients with peritoneal carcinomatosis (1993) (254)
Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. (1990) (254)
A review of peritoneal mesothelioma at the Washington Cancer Institute. (2003) (249)
Hepatic tumors: comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation. (1989) (248)
Prospective Morbidity and Mortality Assessment of Cytoreductive Surgery Plus Perioperative Intraperitoneal Chemotherapy To Treat Peritoneal Dissemination of Appendiceal Mucinous Malignancy (2006) (248)
Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer. (1985) (246)
Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon. (1994) (245)
Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases. (1988) (244)
Surgery for colorectal cancer metastatic to the liver. Optimizing the results of treatment. (1989) (240)
Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy (1996) (236)
Phase I and Pharmacological Studies of Adriamycin Administered Intraperitoneally to Patients with Ovarian Cancer (1982) (233)
Immunohistochemical Evidence Supporting the Appendiceal Origin of Pseudomyxoma Peritonei in Women (1997) (232)
Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. (1989) (231)
Hepatic Resection of Coiorectal Metastases: Influence of Clinical Factors and Adjuvant Intraperitoneal 5‐Fluorouracil via Tenckhoff Catheter on Survival (1985) (230)
Intraperitoneal cancer dissemination: Mechanisms of the patterns of spread (2003) (222)
Laparotomy enhances intraperitoneal tumor growth and abrogates the antitumor effects of interleukin-2 and lymphokine-activated killer cells. (1987) (218)
Clinical perspective of human colorectal cancer metastasis (2004) (214)
Characteristics of cell lines established from human colorectal carcinoma. (1987) (208)
Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans. (1981) (207)
Update on the surgical approach to mucocele of the appendix. (2006) (206)
Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. (2001) (205)
A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma (2007) (199)
Peritoneal Carcinomatosis: Principles of Management (2011) (197)
Treatment of primary colon cancer with peritoneal carcinomatosis (2000) (195)
Clinical presentation of the pseudomyxoma peritonei syndrome (2000) (195)
Bologna guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO): 2013 update of the evidence-based guidelines from the world society of emergency surgery ASBO working group (2013) (192)
Peritoneal Approach to Prosthetic Mesh Repair of Paraostomy Hernias (1985) (190)
Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. (1998) (190)
Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma. (1987) (180)
Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology. (1996) (180)
Guidelenines in the management of obstructing cancer of the left colon: consensus conference of the world society of emergency surgery (WSES) and peritoneum and surgery (PnS) society (2010) (178)
Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities (1983) (177)
Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy. (2005) (174)
Malignant transformation of “benign” cystic mesothelioma of the peritoneum (2002) (173)
Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: A multi‐institutional study (2010) (173)
Thermal Enhancement of New Chemotherapeutic Agents at Moderate Hyperthermia (2003) (169)
Results of treatment of 33 patients with peritoneal mesothelioma (2000) (167)
A simplified plan for follow-up of patients with colon and rectal cancer supported by prospective studies of laboratory and radiologic test results. (1987) (167)
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. (2007) (165)
The morphologic spectrum of ovarian metastases of appendiceal adenocarcinomas: a clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites. (1997) (162)
Surgical decision making for large bowel cancer metastatic to the liver. (1990) (161)
Bologna Guidelines for Diagnosis and Management of Adhesive Small Bowel Obstruction (ASBO): 2010 Evidence-Based Guidelines of the World Society of Emergency Surgery (2011) (158)
Clinical Pathway for the Management of Resectable Gastric Cancer with Peritoneal Seeding: Best Palliation with a Ray of Hope for Cure (2000) (158)
Gastrointestinal malignancy: Rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy (1989) (151)
Results of multimodality therapy of resectable soft-tissue sarcomas of the retroperitoneum. (1985) (149)
Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach? (2012) (148)
Indications for Early Postoperative Intraperitoneal Chemotherapy of Advanced Gastric Cancer: Results of a Prospective Randomized Trial (2001) (148)
Repeat liver resections from colorectal metastasis (1995) (148)
Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity. (1988) (147)
Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model (1997) (147)
Malignant pseudomyxoma peritonei of colonic origin (1987) (147)
Influence of surgical techniques on survival in patients with colorectal cancer (1982) (146)
Aggressive Resection of Metastatic Disease in Selected Patients with Malignant Gastrinoma (1986) (145)
Epithelial Appendiceal Neoplasms (2009) (145)
Second-look Surgery after Cytoreduction and Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer: Analysis of Prognostic Features (1999) (144)
Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy (2005) (142)
Quantitative analyses of selective radiolabeled monoclonal antibody localization in metastatic lesions of colorectal cancer patients. (1987) (140)
A novel tumor‐node‐metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi‐institutional database * (2011) (140)
Heated Intraoperative Intraperitoneal Mitomycin C and Early Postoperative Intraperitoneal 5-Fluorouracil: Pharmacokinetic Studies (1998) (137)
Diagnosis and treatment of peritoneal mesothelioma: The Washington Cancer Institute experience. (2002) (136)
A new standard of care for the management of peritoneal surface malignancy. (2011) (132)
Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. (1995) (131)
Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer. (2007) (131)
Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered MAb B72.3 (1987) (131)
Musculoskeletal cancer surgery : treatment of sarcomas and allied diseases (2001) (130)
Prognostic Indicators for Patients Undergoing Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Diffuse Malignant Peritoneal Mesothelioma† (2006) (130)
Critical Analysis of Treatment Failure After Complete Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Peritoneal Dissemination From Appendiceal Mucinous Neoplasms (2007) (129)
Lymphatic dissemination of hepatic metastases. Implications for the follow‐up and treatment of patients with colorectal cancer (1985) (128)
Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum (2003) (126)
Neoadjuvant treatment of gastric cancer with peritoneal dissemination. (2006) (126)
Incomplete Cytoreduction in 174 Patients With Peritoneal Carcinomatosis From Appendiceal Malignancy (2004) (125)
Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer. (2003) (125)
The Use of Preoperative Plasma CEA Levels for the Stratification of Patients After Curative Resection of Colorectal Cancers (1980) (119)
Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration. (1996) (118)
Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy (2007) (117)
A randomized, prospective trial of adjuvant chemotherapy in adults with soft tissue sarcomas of the head and neck, breast, and trunk (1985) (116)
Morbidity and mortality of cytoreductive surgery and intraperitoneal chemotherapy. (1993) (115)
Peritoneal carcinomatosis from appendiceal cancer: Results in 69 patients treated by cytoreductive surgery and intraperitoneal chemotherapy (1993) (115)
A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. (2007) (114)
Serial carcinoembryonic antigen assays. Use in detection of cancer recurrence. (1974) (114)
Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment. (1999) (114)
Comprehensive management of diffuse malignant peritoneal mesothelioma. (2006) (114)
Radioimmunoscintigraphy of colon cancer with iodine-131-labeled B72.3 monoclonal antibody. (1988) (112)
Liver metastasis detection: comparative sensitivities of MR imaging and CT scanning. (1987) (112)
Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites. (2006) (106)
Ovarian metastasis from colorectal cancer (1986) (103)
Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (low malignant potential) tumors of the ovary. (1997) (103)
Preoperative localization of focal liver lesions to specific liver segments: utility of CT during arterial portography. (1990) (103)
Repeat hepatic resections for colorectal metastases (1990) (103)
Assessment of serial carcinoembryonic antigen (CEA) assays in postoperative detection of recurrent colorectal cancer (1976) (102)
Appendiceal mucocele. Contraindication to laparoscopic appendectomy. (1998) (100)
Peritoneum as the first‐line of defense in carcinomatosis (2007) (99)
Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum (2016) (97)
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: First Report of the HYPER-O Registry (2009) (97)
Hemodynamic and Cardiac Function Parameters During Heated Intraoperative Intraperitoneal Chemotherapy Using the Open “Coliseum Technique” (2000) (95)
The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI). (2018) (93)
A prospective study of hepatic imaging in the detection of metastatic disease. (1982) (93)
Safety monitoring of the coliseum technique for heated intraoperative intraperitoneal chemotherapy with mitomycin C (2002) (92)
Prognostic Assessment of Gastrointestinal Stromal Tumor (2003) (91)
Pharmacokinetics and Pharmacodynamics of Perioperative Cancer Chemotherapy in Peritoneal Surface Malignancy (2009) (91)
A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent. (2016) (87)
Neoadjuvant FOLFOX chemotherapy in 34 consecutive patients with mucinous peritoneal carcinomatosis of appendiceal origin (2010) (87)
Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis. (2015) (85)
Second-Look Surgery in Patients With Peritoneal Dissemination From Appendiceal Malignancy: Analysis of Prognostic Factors in 98 Patients (2001) (84)
Appendiceal mucocele (1998) (84)
Failure Analysis of Recurrent Disease Following Complete Cytoreduction and Perioperative Intraperitoneal Chemotherapy in Patients with Peritoneal Carcinomatosis from Colorectal Cancer (2007) (84)
Surgical technology and pharmacology of hyperthermic perioperative chemotherapy. (2016) (84)
Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics (2003) (83)
Diagnosis and Management of Peritoneal Metastases from Ovarian Cancer (2012) (83)
Clinical Presentation of Peritoneal Mesothelioma (2003) (83)
Anastomotic leak after double-stapled low colorectal resection (1996) (82)
Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma. (2006) (82)
Peritoneal Cystic Mesothelioma: A Case Series (2003) (81)
Morbidity and Mortality Assessment of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Diffuse Malignant Peritoneal Mesothelioma—A Prospective Study of 70 Consecutive Cases (2007) (81)
The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer. (2004) (80)
Histopathologic Analysis in 46 Patients with Pseudomyxoma Peritonei Syndrome: Failure versus Success with a Second-Look Operation (2001) (80)
Clinical Perspective on Desmoplastic Small Round-Cell Tumor (2004) (79)
Surgical responsibilities in the management of peritoneal carcinomatosis (2010) (77)
Prospective randomized trial of intravenous v intraperitoneal 5-FU in patients with advanced primary colon or rectal cancer. (1985) (76)
Peritoneal carcinomatosis: natural history and rational therapeutic interventions using intraperitoneal chemotherapy. (1996) (75)
Pharmacokinetics of intraperitoneal oxaliplatin: Experimental studies (2001) (74)
Systemic Chemotherapy prior to Cytoreductive Surgery and HIPEC for Carcinomatosis from Appendix Cancer: Impact on Perioperative Outcomes and Short-Term Survival (2012) (73)
Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model (2002) (72)
A Prospective Analysis of Laboratory Tests and Imaging Studies To Detect Hepatic Lesions (1982) (72)
Evaluation of clonal origin of malignant mesothelioma (2014) (72)
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastrointestinal cancers with peritoneal metastases: Progress toward a new standard of care. (2016) (71)
Local regional promotion of tumor growth after abdominal surgery is dominant over immunotherapy with interleukin-2 and lymphokine activated killer cells. (1988) (71)
Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin. (1996) (70)
Update on the prevention of local recurrence and peritoneal metastases in patients with colorectal cancer. (2014) (70)
Surgical treatment of peritoneal carcinomatosis: 1988 Du Pont lecture. (1989) (69)
Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival. (2017) (69)
Intrapelvic prosthesis to prevent injury of the small intestine with high dosage pelvic irradiation. (1983) (69)
Multi‐institutional experience of diffuse intra‐abdominal multicystic peritoneal mesothelioma (2011) (68)
Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions (2003) (68)
Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C (2006) (68)
Pleural extension of mucinous tumor in patients with pseudomyxoma peritonei syndrome (2000) (67)
A simplified approach to hyperthermic intraoperative intraperitoneal chemotherapy (HIIC) using a self retaining retractor. (1996) (67)
Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei (2014) (66)
Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference. (2006) (66)
[Elective surgery in recurrent colon cancer with peritoneal seeding: when to and when not to proceed]. (1999) (65)
Technical considerations in the use of intraperitoneal chemotherapy administered by Tenckhoff catheter. (1982) (64)
Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin (2004) (64)
Surgical management of peritoneal carcinosis: Diagnosis, prevention and treatment (2005) (64)
Treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from colorectal or appendiceal mucinous neoplasms (2008) (64)
Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma. (2006) (63)
Histologic changes induced by intraperitoneal chemotherapy with 5‐fluorouracil and mitomycin c in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendix (1990) (63)
Congenital duplication of the gallbladder associated with an anomalous right hepatic artery. (1985) (63)
Sex difference in diffuse malignant peritoneal mesothelioma (2006) (63)
Cytoreductive Surgery Plus Hyperthermic Perioperative Chemotherapy for Selected Patients with Peritoneal Metastases from Colorectal Cancer: A New Standard of Care or an Experimental Approach? (2012) (61)
Intraperitoneal chemotherapy for treatment and prevention of peritoneal carcinomatosis and sarcomatosis (1994) (61)
Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis (2011) (61)
Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy as a Curative Approach to Pseudomyxoma Peritonei Syndrome (2001) (61)
Complete cytoreductive surgery plus HIPEC for peritoneal metastases from unusual cancer sites of origin: results from a worldwide analysis issue of the Peritoneal Surface Oncology Group International (PSOGI) (2017) (61)
Heated IntraPEritoneal Chemotherapy (HIPEC) for Patients With Recurrent Ovarian Cancer: A Systematic Literature Review (2016) (60)
Dissection by electrocautery with a ball tip (1994) (60)
Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer (1995) (60)
Prosthetic mesh repair of large hernias at the site of colonic stomas. (1980) (60)
Peritoneal carcinomatosis: preoperative CT with intraperitoneal contrast material. (1992) (60)
Impact of carrier solutions on pharmacokinetics of intraperitoneal chemotherapy (2001) (59)
Rate of growth of intraabdominal metastases from colorectal cancer (1984) (59)
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement (2007) (58)
Review of a personal experience in the management of carcinomatosis and sarcomatosis. (2001) (57)
Asbestos and Peritoneal Mesothelioma among College-educated Men (2005) (57)
Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma. (2002) (57)
Metastatic inefficiency: The scientific basis for resection of liver metastases from colorectal cancer (1993) (57)
Colorectal Cancer: Prevention and Management of Metastatic Disease (2014) (56)
Surgically directed chemotherapy: heated intraperitoneal lavage with mitomycin C. (1996) (55)
Pharmacokinetics of Intraperitoneal Gemcitabine in a Rat Model (1998) (53)
Peritoneal carcinomatosis from gastrointestinal malignancy: natural history and new prospects for management. (1994) (53)
Radiology of peritoneal carcinomatosis. (1996) (53)
Peritoneal Carcinomatosis from Adenocarcinoma of the Colon (2014) (53)
Cytoreduction including total gastrectomy for pseudomyxoma peritonei. (2002) (53)
Bologna guidelines for diagnosis and management (2013) (53)
Differences in biodistribution of indium-111-and iodine-131-labeled B72.3 monoclonal antibodies in patients with colorectal cancer. (1989) (52)
Mucinous colorectal carcinoma (2001) (52)
Cancer recurrence following laparoscopic colectomy (1995) (52)
Hemipelvectomy for Buttock Tumors Utilizing an Anterior Myocutaneous Flap of Quadriceps Femoris Muscle (1983) (51)
Impact of surgical and clinical factors on the pharmacology of intraperitoneal doxorubicin in 145 patients with peritoneal carcinomatosis. (2011) (51)
Gastrointestinal Complications in 147 Consecutive Patients with Peritoneal Surface Malignancy Treated by Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy (2011) (51)
Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer. (2010) (51)
The Tikhoff-Linberg procedure: report of ten patients and presentation of a modified technique for tumors of the proximal humerus. (1985) (51)
Peritoneal carcinomatosis from adenocarcinoma of the colon. (1996) (51)
A pharmacologic analysis of intraoperative intracavitary cancer chemotherapy with doxorubicin (2009) (50)
Treatment of peritoneal carcinomatosis from colon or appendiceal cancer with induction intraperitoneal chemotherapy. (1996) (50)
CT of the liver and spleen with EOE-13: review of 225 examinations. (1984) (50)
Bone and Soft-tissue Sarcomas: Epidemiology, Radiology, Pathology and Fundamentals of Surgical Treatment (2004) (50)
Comprehensive management of peritoneal surface malignancy using cytoreductive surgery and perioperative intraperitoneal chemotherapy: the Washington Cancer Institute approach (2009) (49)
Treatment of proximal biliary tract carcinoma: an overview of techniques and results. (1985) (49)
Effect of intraperitoneal administration of docetaxel on peritoneal dissemination of gastric cancer. (2004) (49)
Peritoneal Carcinomatosis: Drugs and Diseases (2011) (49)
Patterns of serial CEA assays and their clinical use in management of colorectal cancer (1976) (49)
The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery. (2021) (48)
Carcinoembryonic Antigen (CEA) Assays in Obstructive Colorectal Cancer (1976) (47)
Pseudomyxoma peritonei in a hernia sac: analysis of 20 patients in whom mucoid fluid was found during a hernia repair. (2001) (46)
Effect of intraperitoneal chemotherapy and fibrinolytic therapy on tumor implantation in wound sites (1996) (46)
Lymph Node Metastasis in Epithelial Malignancies of the Appendix With Peritoneal Dissemination Does Not Reduce Survival in Patients Treated by Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy (2005) (46)
Importance of gender in diffuse malignant peritoneal mesothelioma. (2012) (46)
Carcinomatosis--is cure an option? (2003) (46)
It's what the surgeon doesn't see that kills the patient. (2000) (46)
Perineal and bladder necrosis following bilateral internal iliac artery ligation report of a case (1985) (45)
Management of Malignant Peritoneal Mesothelioma Using Cytoreductive Surgery and Perioperative Chemotherapy. (2016) (45)
Second-Look Surgery for Colorectal Cancer: Revised Selection Factors and New Treatment Options for Greater Success (2010) (45)
Major amputations done with palliative intent in the treatment of local bony complications associated with advanced cancer (1991) (45)
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms (2020) (44)
Peritoneal surface oncology: review of a personal experience with colorectal and appendiceal malignancy (2005) (44)
Management of metastatic cancer to the liver. (1989) (44)
Repeat liver resections from colorectal metastasis. Repeat Hepatic Metastases Registry. (1995) (43)
A curative approach to peritoneal carcinomatosis from colorectal cancer. (2005) (43)
Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer (2009) (43)
Carrier solutions for intraperitoneal chemotherapy. (2003) (42)
Drugs, doses, and durations of intraperitoneal chemotherapy: standardising HIPEC and EPIC for colorectal, appendiceal, gastric, ovarian peritoneal surface malignancies and peritoneal mesothelioma (2017) (42)
An instrument to provide containment of intraoperative intraperitoneal chemotherapy with optimized distribution (2005) (42)
Laser-mode electrosurgery. (1996) (42)
Mucinous adenocarcinoma of the small bowel with peritoneal seeding. (2002) (42)
Update on the management of malignant peritoneal mesothelioma. (2018) (42)
Peritoneal mesothelioma: treatment approach based on natural history. (1996) (42)
Pharmacology of perioperative 5‐Fluorouracil (2010) (42)
A comparison of hetastarch and peritoneal dialysis solution for intraperitoneal chemotherapy delivery. (2003) (42)
Pharmacokinetics of the peritoneal-plasma barrier after systemic mitomycin C administration. (1996) (41)
Surgical management of carcinomatosis from colorectal cancer. (2005) (41)
Carcinoma of the colon--prognosis and operative choice. (1981) (41)
Computed tomography of the liver and spleen with intravenous lipoid contrast material: review of 60 examinations. (1982) (41)
In vitro growth of murine T cells. VI. Accelerated skin graft rejection caused by adoptively transferred cells expanded in T cell growth factor. (1981) (41)
Rectovaginal fistula following low circular stapled anastomosis in women with rectal cancer (1996) (41)
Complete parietal and visceral peritonectomy of the pelvis for advanced primary and recurrent ovarian cancer. (1996) (41)
Pharmacology of perioperative intraperitoneal and intravenous chemotherapy in patients with peritoneal surface malignancy. (2012) (40)
Patterns of spread of recurrent intraabdominal sarcoma. (1996) (40)
New Perspectives in the Management of Colorectal Cancer: What about Peritoneal Carcinomatosis? (2003) (40)
[Tumor implantation in cicatrization sites following surgery for digestive cancers]. (1996) (40)
Intraperitoneal taxanes. (2003) (39)
Docetaxel and hyperthermia: Factors that modify thermal enhancement (2004) (39)
Morbidity and mortality of early postoperative intraperitoneal chemotherapy as adjuvant therapy for gastric cancer. (1998) (38)
Molecular Genetic Analysis of Appendiceal Mucinous Adenomas in Identical Twins, Including One With Pseudomyxoma Peritonei (2001) (38)
Peritoneal carcinomatosis: imaging with intraperitoneal injection of I-131-labeled B72.3 monoclonal antibody. (1988) (38)
Pharmacokinetic Study of Perioperative Intravenous Ifosfamide (2011) (38)
Clinically aggressive pseudomyxoma peritonei: A variant of a histologically indolent process (2004) (38)
Intraperitoneal Gemcitabine Chemotherapy Treatment for Patients with Resected Pancreatic Cancer: Rationale and Report of Early Data (2011) (38)
Pulmonary Complications following Cytoreductive Surgery and Perioperative Chemotherapy in 147 Consecutive Patients (2012) (37)
Morbidity and mortality of hepatic resection for metastatic colorectal carcinoma (1990) (37)
Current status and future prospects of clinical trials on CRS + HIPEC for gastric cancer peritoneal metastases (2017) (37)
Pharmacokinetics and tissue distribution of intraperitoneal docetaxel with different carrier solutions. (2003) (37)
Transient carcinoembryonic antigen (CEA) elevations following resection of colorectal cancer: a limitation in the use of serial CEA levels as an indicator for second-look surgery. (1978) (37)
Management of peritoneal surface malignancy (2003) (36)
Intra-abdominal extrahepatic disease in patients with colorectal hepatic metastases (1988) (36)
Managing the peritoneal surface component of gastrointestinal cancer. Part 2. Perioperative intraperitoneal chemotherapy. (2004) (36)
The natural history, gross pathology, and histopathology of appendiceal epithelial neoplasms. (2006) (36)
Concerning CT features used to select patients for treatment of peritoneal metastases, a pictoral essay (2017) (36)
Peritoneal mesothelioma proposal for a staging system. (2001) (36)
Using Pharmacologic Data to Plan Clinical Treatments for Patients with Peritoneal Surface Malignancy (2009) (35)
Computed Tomographic Characterization of Malignant Peritoneal Mesothelioma (2005) (35)
Repeat hepatectomy for colorectal metastases. (1999) (35)
Hyperthermic Intraoperative Thoracoabdominal Chemotherapy (2012) (35)
Third look surgery and beyond for appendiceal malignancy with peritoneal dissemination (2003) (35)
Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience (2018) (34)
Methodologic considerations in treatment using intraperitoneal chemotherapy. (1996) (34)
Effect of intraperitoneal chemotherapy and peritoneal lavage in positive peritoneal cytology in gastric cancer. Systematic review and meta-analysis. (2016) (34)
Avoiding Diverting Ileostomy in Patients Requiring Complete Pelvic Peritonectomy (2016) (33)
Management of peritoneal metastases - Basic concepts. (2015) (33)
Cytoreductive surgery using peritonectomy and visceral resections for peritoneal surface malignancy (2013) (33)
Tumor targeting with monoclonal antibody B72.3. (1989) (33)
A segmental approach to computerized tomographic portography for hepatic resection. (1990) (33)
Hyperthermic Intraperitoneal Chemotherapy with Melphalan: A Summary of Clinical and Pharmacological Data in 34 Patients (2012) (32)
Intraoperative hyperthermic lavage with cisplatin for peritoneal carcinomatosis and sarcomatosis. (1996) (32)
Prognostic features for peritoneal carcinomatosis in colorectal and appendiceal cancer patients when treated by cytoreductive surgery and intraperitoneal chemotherapy. (1996) (32)
Clinical trials with a new intravenous liposoluble contrast material for computed tomography of the liver and spleen. (1980) (32)
Cytoreductive surgery and perioperative intraperitoneal chemotherapy: a new standard of care for appendiceal mucinous tumors with peritoneal dissemination. (2005) (32)
Strategies for the Prevention and Treatment of Peritoneal Carcinomatosis from Gastrointestinal Cancer (2005) (32)
Initiation of a program in peritoneal surface malignancy. (2003) (32)
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Methodology, Drugs and Bidirectional Chemotherapy (2016) (31)
New prospects for the control of peritoneal surface dissemination of gastric cancer using perioperative intraperitoneal chemotherapy (2004) (31)
Musculoskeletal Cancer Surgery (2001) (31)
Improved detection of focal lesions with computerized tomographic examination of the liver using ethiodized oil emulsion (EOE‐13) liver contrast (1984) (31)
Immunotherapy of intraperitoneal cancer with interleukin 2 and lymphokine-activated killer cells reduces tumor load and prolongs survival in murine models. (1987) (31)
Peritoneal Metastases from Gastrointestinal Cancer (2018) (31)
Limited Survival in the Treatment of Carcinomatosis From Rectal Cancer (2005) (30)
Managing the peritoneal surface component of gastrointestinal cancer. Part 1. Patterns of dissemination and treatment options. (2004) (30)
A Prospective Study of Hepatic Imaging in the Detection of Metastatic Disease (1982) (30)
Detection of hepatic metastases: comparison of EOE-13 computed tomography and scintigraphy. (1983) (30)
Strategies for management of the peritoneal surface component of cancer: cytoreductive surgery plus perioperative intraperitoneal chemotherapy (2005) (30)
Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin. (2020) (29)
Pathobiology of peritoneal carcinomatosis from ovarian malignancy. (1996) (29)
Causes of death in patients undergoing liver surgery. (1994) (29)
Early postoperative intraperitoneal Adriamycin as an adjuvant treatment for visceral and retroperitoneal sarcoma. (1996) (29)
Partial sacrectomy foren bloc excision of rectal cancer with posterior fixation (1982) (29)
Total anterior parietal peritonectomy (2003) (29)
Prior Surgical Score: An Analysis of the Prognostic Significance of an Initial Nondefinitive Surgical Intervention in Patients With Peritoneal Carcinomatosis of a Colorectal Origin Undergoing Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy (2018) (29)
Management of Mucinous Urachal Neoplasm Presenting as Pseudomyxoma Peritonei (2008) (28)
Perioperative intraperitoneal chemotherapy for peritoneal surface malignancy (2006) (28)
Recurrent intraabdominal cancer with intestinal obstruction. (1995) (28)
Clinical determinants of treatment failure in patients with pseudomyxoma peritonei. (1996) (28)
Cytoreduction including total gastrectomy for pseudomyxoma peritonei (2002) (28)
Compartment syndrome of the leg associated with lithotomy position for cytoreductive surgery (2007) (28)
Hyperthermia modifies pharmacokinetics and tissue distribution of intraperitoneal melphalan in a rat model (2004) (28)
Improving oncologic outcomes for colorectal cancer at high risk for local–regional recurrence with novel surgical techniques (2016) (27)
Prevention and Treatment of Peritoneal Metastases: a Comprehensive Review (2019) (27)
Prospective studies of laboratory and radiologic tests in the management of colon and rectal cancer patients: I (1984) (27)
Childbearing After Hyperthermic Intraperitoneal Chemotherapy: Results From an International Survey (2011) (27)
When and When Not to Perform a Right Colon Resection with Mucinous Appendiceal Neoplasms (2017) (27)
Cytoreductive surgery and intraperitoneal chemotherapy with peritoneal spread of cystadenocarcinoma. (1991) (27)
Surgical technique and colorectal cancer: impaction on local recurrence and survival. (1995) (27)
Clinicopathologic and Prognostic Features in Patients with Peritoneal Metastasis from Mucinous Adenocarcinoma, Adenocarcinoma with Signet Ring Cells, and Adenocarcinoid of the Appendix Treated with Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy (2016) (27)
Krukenberg syndrome as a natural manifestation of tumor cell entrapment. (1996) (27)
Cytoreductive Surgery and HIPEC as a Treatment Option for Laparoscopic Resection of Uterine Leiomyosarcoma with Morcellation: Early Results (2016) (27)
Neutropenia following Perioperative Intraperitoneal Chemotherapy (1999) (26)
Perioperative outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy for non‐appendiceal peritoneal carcinomatosis from a prospective database (2007) (26)
Intraperitoneal chemotherapy for peritoneal carcinomatosis from colonic or appendiceal cystadenocarcinoma: rationale and results of treatment. (1990) (26)
Transureteroureterostomy: an adjunct to the management of advanced primary and recurrent pelvic malignancy (2002) (26)
Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi‐institutional experience (2018) (26)
Pharmacokinetics of Hyperthermic Intrathoracic Chemotherapy following Pleurectomy and Decortication (2012) (26)
Hyperthermic intraoperative intraperitoneal chemotherapy safety considerations. (1996) (26)
Preoperative Assessment of Cancer Patients with Peritoneal Metastases for Complete Cytoreduction (2016) (26)
Contraindication to laparoscopic appendectomy (1998) (25)
Pont hepatique (hepatic bridge), an important anatomic structure in cytoreductive surgery (2010) (25)
Carcinoembryonic antigen (CEA) monitoring of radiation therapy for colorectal cancer. (1976) (25)
Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study. (2018) (25)
Cytoreduction of the small bowel surfaces (2008) (25)
Liver transection: a controlled study of four different techniques in pigs. (1985) (25)
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Gastric Metastases (2020) (25)
Detection of hepatic metastases from cancer of the breast. (1977) (24)
Multi-targeted antifolate (MTA): pharmacokinetics of intraperitoneal administration in a rat model. (2000) (24)
Pseudomyxoma peritonei from mucinous adenocarcinoma of the urachus. (2006) (24)
Management of appendiceal pseudomyxoma peritonei diagnosed during pregnancy (2009) (24)
Adjuvant Bidirectional Chemotherapy with Intraperitoneal Pemetrexed Combined with Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma (2012) (24)
Colonoscopy in the management of diseases of the colon and rectum. (1974) (24)
Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution’s Experience During Two Decades (2017) (23)
Sarcomas Involving the Abdominal and Pelvic Cavity (1993) (23)
The subpyloric space: an important surgical and radiologic feature in pseudomyxoma peritonei. (2002) (23)
Sister Mary Joseph's sign. (2001) (23)
Are there curative options to peritoneal carcinomatosis? (2005) (23)
Pharmacokinetics of the Perioperative Use of Cancer Chemotherapy in Peritoneal Surface Malignancy Patients (2012) (23)
Body surface area‐based vs concentration‐based perioperative intraperitoneal chemotherapy after optimal cytoreductive surgery in colorectal peritoneal surface malignancy treatment: COBOX trial (2019) (23)
Toxicity Studies of Adjuvant Intravenous Versus Intraperitoneal 5‐FU in Patients with Advanced Primary Colon or Rectal Cancer (1986) (23)
The Chicago Consensus Guidelines for peritoneal surface malignancies: Introduction (2020) (23)
Radical appendectomy as an alternative to right colon resection in patients with epithelial appendiceal neoplasms. (2017) (22)
Fiberoptic colonoscopy. A new look at old problems. (1973) (22)
Is Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Justified for Biphasic Variants of Peritoneal Mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry (2018) (22)
A perspective on clinical research strategies in carcinoma of the large bowel (1991) (21)
Early distant metastases from epithelioid sarcoma of the hand (1981) (21)
The Chicago Consensus on peritoneal surface malignancies: Palliative care considerations (2020) (21)
Preferential homing of passively transferred T cells into skin allografts of mice. (1979) (21)
Evolution of cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis: are there treatment alternatives? (2011) (21)
Early localized peritoneal mesothelioma as an incidental finding at laparoscopy (2000) (21)
Efficacy of chemoimmunotherapy with cyclophosphamide, interleukin-2 and lymphokine activated killer cells in an intraperitoneal murine tumour model. (1988) (21)
Iterative Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent or Progressive Diffuse Malignant Peritoneal Mesothelioma: Clinicopathologic Characteristics and Survival Outcome (2015) (21)
The Chicago Consensus on Peritoneal Surface Malignancies: Standards (2020) (21)
Radiolabeled monoclonal antibody B72.3 localization in metastatic lesions of colorectal cancer patients. (1987) (20)
Malignant peritoneal mesothelioma. Case-report demonstrating pitfalls of diagnostic laparoscopy. (1997) (20)
Palliation with a glimmer of hope: management of resectable gastric cancer with peritoneal carcinomatosis. (2001) (20)
Cholecystectomy, lesser omentectomy, and stripping of the omental bursa: A peritonectomy procedure (2003) (20)
The Chicago Consensus on peritoneal surface malignancies: Management of appendiceal neoplasms (2020) (20)
Peritonectomy procedures. (1995) (20)
Rosai-Dorfman disease (sinus histiocytosis with massive lymphadenopathy) of the pancreas: first case report. (1999) (20)
Prognostic factor analysis of circulating tumor cells in peripheral blood of patients with peritoneal carcinomatosis of colon cancer origin treated with cytoreductive surgery plus an intraoperative hyperthermic intraperitoneal chemotherapy procedure (CRS + HIPEC). (2016) (20)
Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus (2015) (20)
Evolution of Treatments for Peritoneal Metastases From Colorectal Cancer. (2015) (20)
Congenital pleuroperitoneal communication in a patient with pseudomyxoma peritonei (2000) (20)
Femoral artery based myocutaneous flap for hemipelvectomy closure: amputation after failed limb-sparing surgery and radiotherapy. (1985) (20)
The requirements for successful immunotherapy of intraperitoneal cancer using interleukin‐2 and lymphokine‐activated killer cells (1987) (19)
Intraperitoneal chemotherapy and immunotherapy. (1991) (19)
Overview of the optimal perioperative intraperitoneal chemotherapy regimens used in current clinical practice (2017) (19)
Hyperthermic intraoperative intreperitoneal chemotherapy (HIIC) with mitomycin C. (1996) (19)
Appendiceal Epithelial Neoplasms and Pseudomyxoma Peritonei, A Distinct Clinical Entity With Distinct Treatments (2007) (19)
Below-knee Amputation (2004) (19)
Pharmacokinetics of the intraperitoneal nanoparticle pegylated liposomal doxorubicin in patients with peritoneal metastases. (2019) (19)
Adjuvant Bidirectional Chemotherapy Using an Intraperitoneal Port (2012) (19)
Management of peritoneal carcinomatosis. (1989) (19)
Iliac arterial-enteric fistulas occurring after pelvic irradiation. (1987) (19)
Pharmacokinetic and phase II study of heated intraoperative intraperitoneal melphalan (2006) (19)
The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: A web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI). (2021) (19)
Revised guidelines for second-look surgery in patients with colon and rectal cancer (2010) (19)
Early intervention for treatment and prevention of colorectal carcinomatosis: a plan for individualized care. (2012) (19)
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumors (2020) (19)
Role of carcinoembryonic antigen assay in the management of cancer. (1985) (19)
The influence of tumor cell entrapment phenomenon on the natural history of Pseudomyxoma peritonei syndrome. (2012) (18)
Atlas of extremity sarcoma surgery (1984) (18)
Intraperitoneal chemotherapy and its evolving role in management of gastric cancer with peritoneal metastases. (2014) (18)
Strategies to improve local control of resected pancreas adenocarcinoma. (2017) (18)
Pharmacokinetic studies of intraaortic stop-flow infusion with 14C-labeled mitomycin C. (1995) (18)
Early and long-term outcome data on 2,298 patients with pseudomyxoma peritonei of appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. (2012) (18)
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Peritoneal Mesothelioma (2020) (18)
Surgical treatment of gastric cancer. (1991) (18)
Prolonged Treatment Schedules with Intraperitoneal 5‐Fluorouracil Diminish the Local‐Regional Nature of Drug Distribution (1986) (17)
Gastric cancer: prevention and treatment of peritoneal metastases (2018) (17)
Re: Verwaal VJ, van Tinteren H, Ruth SV, et al.: Toxicity of cytoreductive surgery and hyperthermic intra‐peritoneal chemotherapy. J Surg Oncol 2004; 85:61–67 (2004) (17)
Troubleshooting (1993) (17)
Carcinomatosis from gastrointestinal cancer (2004) (17)
Adverse Events Postoperatively Had No Impact on Long-Term Survival of Patients Treated with Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Appendiceal Cancer with Peritoneal Metastases (2016) (17)
Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: Results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI). (2020) (17)
Calcification of pseudomyxoma peritonei following intraperitoneal chemotherapy: CT demonstration. (1985) (17)
The Porta Hepatis as a Site of Recurrence of Mucinous Appendiceal Neoplasms Treated by Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy (2008) (17)
Early postoperative intraperitoneal chemotherapy for gastric cancer. (1991) (17)
The approval process for hyperthermic intraoperative intraperitoneal chemotherapy. (2006) (17)
Colorectal carcinomatosis: a new oncologic frontier (2005) (16)
Fluoroscopically guided peritoneal catheter placement for intraperitoneal chemotherapy. (1994) (16)
Circumferential cutaneous traction for exposure of the layers of the abdominal wall (2008) (16)
Multi-institutional study of peritoneal sarcomatosis from uterine sarcoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. (2017) (16)
CT in the selection of patients with abdominal or pelvic sarcoma for reoperative surgery. (2000) (16)
Mechanisms of relapse for colorectal cancer: Implications for intraperitoneal chemotherapy (1991) (16)
Early postoperative intraperitoneal adriamycin as an adjuvant treatment for advanced gastric cancer with lymph node or serosal invasion. (1991) (16)
Peritoneal Metastases, a Frontier for Progress. (2018) (16)
Localized visceral invasion of peritoneal mesothelioma causing intestinal obstruction: a new clinical presentation. (2005) (16)
The Chicago Consensus on peritoneal surface malignancies: Management of gastric metastases (2020) (16)
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms (2020) (16)
Body surface area-based versus concentration-based intraperitoneal perioperative chemotherapy in a rat model of colorectal peritoneal surface malignancy: pharmacologic guidance towards standardization (2019) (15)
Peritoneal Carcinomatosis of Urachus Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An International Registry of 36 Patients (2018) (15)
Home parenteral nutrition for patients with advanced intraperitoneal cancers and gastrointestinal dysfunction (1986) (15)
Peritoneal Carcinomatosis from an Unknown Primary Site. Management of 15 Patients (2001) (15)
Unusual abdominal tumors, case 1. Pseudomyxoma peritonei: response to capecitabine. (2004) (15)
The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms (2020) (15)
En bloc resection of hepatic segments 4B, 5 and 6 by transverse hepatectomy. (1990) (15)
Uncovered skin grafts in mice. (1979) (15)
Peritoneal mesothelioma (2019) (15)
Using celioscopy to determine stages of intra-abdominal malignant neoplasms. (1976) (15)
Registries on peritoneal surface malignancies throughout the world, their use and their options (2017) (14)
Segmental Hyperlucent Defects in the Liver (1984) (14)
Glove starch granulomatous disease. An unsolved surgical problem. (1974) (14)
Hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases: lessons learned from PRODIGE 7. (2020) (14)
Adjuvant Intraperitoneal Chemotherapy for Advanced Primary Gastric Cancer (2006) (14)
van Ruth S, Bronkhorst MWGA, van Coeverden F, Zoetmulder FAN. Peritoneal benign cystic mesothelioma: a case report and review of literature. Eur J Surg Oncol 2002; 28(2): 192-5. (2002) (14)
Sclerosing encapsulating peritonitis as a potential complication of cytoreductive surgery and HIPEC: Clinical features and results of treatment in 4 patients. (2018) (14)
Prevention of intraperitoneal adhesions by intraperitoneal lavage and intraperitoneal 5-fluorouracil: experimental studies. (2002) (14)
New Responsibilities in the Management of Colorectal Cancer with Peritoneal Seeding (2002) (14)
Abdominal adhesions causing intestinal obstruction following cytoreductive surgery and early postoperative intraperitoneal chemotherapy (1995) (14)
Rationale for an intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer. (2009) (14)
A new bidirectional intraperitoneal and systemic induction chemotherapy (BISIC) for the peritoneal metastasis from gastric cancer in neoadjuvant setting (2014) (13)
Parietal Peritonectomy (2012) (13)
Five Reasons Why Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Must be Regarded as the New Standard of Care for Diffuse Malignant Peritoneal (2010) (13)
Increasing phantom limb pain as a symptom of cancer recurrence (1984) (13)
Effects of the Fiberoptic Laparoscope and Colonoscope on Morbidity and Cost (1974) (13)
Mapping the location of peritoneal metastases using the peritoneal cancer index and the correlation with overall survival: a retrospective study. (2015) (13)
Long term survival in patients with peritoneal metastasised gastric cancer treated with cytoreductive surgery and HIPEC: A multi-institutional cohort from PSOGI. (2020) (13)
Splenic Metastases from Mucinous Neoplasms of the Appendix and Colon (2006) (13)
Musculoskeletal surgery for cancer: Principles and techniques (1992) (13)
Discordant Histology of Primary Appendiceal Adenocarcinoid Neoplasms with Peritoneal Dissemination (2008) (13)
Colorectal cancer metastases: a surgical perspective. (2013) (13)
Clinical Pathway for Peritoneal Carcinomatosis from Colon and Rectal Cancer: Guidelines for Current Practice (1997) (13)
Radical forequarter amputation with chest wall resection. (1984) (12)
Ex vivo activation of killer monocytes (AKM) and their application to the treatment of human cancer (1988) (12)
Extremity soft tissue sarcoma with metastases to abdominopelvic surfaces (1997) (12)
ASSESSMENT OF T CELL FUNCTION WITH A SKIN ALLOGRAFT ASSAY (1980) (12)
Pseudomyxoma peritonei arising from colonic polyps. (2006) (12)
Management of peritoneal carcinomatosis from colon cancer, gastric cancer and appendix malignancyArticle (2005) (12)
Improved detection of focal lesions with computerized tomographic examination of the liver using ethiodized oil emulsion (EOE-13) liver contrast. (1984) (12)
Total abdominal colectomy, pelvic peritonectomy, and end‐ileostomy for the surgical palliation of mucinous peritoneal carcinomatosis from non‐gynecologic cancer (2003) (12)
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of advanced epithelial and recurrent ovarian carcinoma: a single center experience (2018) (12)
Adult Respiratory Distress Syndrome Occurring in Two Patients Undergoing Cytoreductive Surgery plus Perioperative Intraperitoneal Chemotherapy: Case Reports and a Review of the Literature (2000) (12)
Synchronous extraperitoneal and intraperitoneal dissemination of appendix cancer. (2004) (12)
Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor (2006) (12)
Proactive management of peritoneal metastases from colorectal cancer: the next logical step toward optimal locoregional control (2012) (11)
Local conditions in the host influence immunotherapy with interleukin-2 and LAK cells. (1988) (11)
Intraperitoneal delivery of chemotherapeutic agents for the treatment of peritoneal metastases: current challenges and how to overcome them (2019) (11)
Peritonectomy procedures. (2007) (11)
Augmentation of interleukin-2 immunotherapeutic effects by lymphokine-activated killer cells and allogeneic stimulation in murine tumor cells. (1987) (11)
Thin-Walled Cysts as a Pathognomonic CT Finding in Cystic Mesothelioma (2008) (11)
The use of drains in elective surgery for colorectal cancer: always, never or selectively? (1995) (11)
Rectal cancer recurrence after prior resection and radiotherapy: palliation following additional surgery (1996) (11)
Methodology in the Clinical Study of Hepatic Metastases (1984) (11)
5‐fluorouracil chemotherapy and pelvic radiation in the treatment of large bowel cancer: Decreased toxicity in combined treatment with 5‐fluorouracil administration through the intraperitoneal route (1986) (11)
Cytoreductive Surgery and Intraperitoneal Chemotherapy (1992) (11)
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Neuroendocrine Tumors (2020) (11)
Intraaortic stop-flow infusion: Pharmacokinetic feasibility study of regional chemotherapy for unresectable gastrointestinal cancers (1995) (11)
Preliminary report of a new treatment strategy for advanced pelvic malignancy: surgical resection and radiation therapy using afterloading catheters plus an inflatable displacement prosthesis in the treatment of advanced primary and recurrent rectal cancer. (1986) (11)
Early postoperative intraperitoneal Adriamycin. Pharmacologic studies and a preliminary clinical report (1991) (11)
Port-Site Metastasis Following Laparoscopic Surgery (2011) (11)
Carcinoembryonic antigen (CEA): Its role as a monitor of radiation therapy for colorectal cancer (1978) (11)
Rectus abdominis muscle resection for abdominal wall recurrence of mucinous adenocarcinoma or peritoneal mesothelioma. (2008) (11)
Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum (2003) (11)
Tumor targeting with monoclonal antibody B72.3: experimental and clinical results. (1990) (11)
Concerning CT features predict outcome of treatment in patients with malignant peritoneal mesothelioma. (2021) (10)
Management of an inguinal hernia in patients with pseudomyxoma peritonei. (2017) (10)
Venobronchial fistula. A rare complication of central venous catheterization for parenteral hyperalimentation. (1973) (10)
Mesenteric Cyst: Report of a Case Resulting in Pseudomyxoma Peritonei (2010) (10)
The role of intraperitoneal chemotherapy in the treatment of patients with advanced gastric cancer. (2012) (10)
The Initial Indian Experience with Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal Metastases (2016) (10)
Follow-up of colorectal cancer. (1995) (10)
Wound recurrence after laparoscopic colectomy for cancer (1996) (10)
Alloimmune cells consume interleukin-2 and competitively inhibit the anti-tumour effects of interleukin-2. (1987) (9)
Management Of Unexpected Peritoneal Metastases With Primary ColorectalCancer Using Second-Look Surgery With HIPEC (2017) (9)
Liver metastasis : basic aspects, detection, and management (1984) (9)
Effects of postoperative intraperitoneal chemotherapy on peritoneal wound healing and adhesion formation. (1996) (9)
Peritoneal metastases from mucinous endocervical adenocarcinoma (2014) (9)
A surgical technique for hip disarticulation. (1981) (9)
Anterior Flap Hemipelvectomy (2004) (9)
Symptoms, signs and radiologic findings in patients having reoperative surgery for malignant peritoneal mesothelioma. (2017) (9)
Ex vivo activated monocytes and adoptive immunotherapy trials in colon cancer patients. (1986) (9)
Regional lymph node metastasis from port site implants after laparoscopic surgery (2004) (9)
Peritoneal carcinomatosis from appendiceal cancer: A paradigm for treatment of abdomino-pelvic dissemination of gastrointestinal malignancy (1996) (9)
Port site metastases after minimally invasive resection for colorectal cancer: A retrospective study of 13 patients. (2019) (9)
The hepatic bridge. (2018) (9)
Techniques of Delivering Hyperthermic Intraperitoneal Chemotherapy (2007) (9)
The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma (2020) (9)
Intraperitoneal gemcitabine chemotherapy is safe for patients with resected pancreatic cancer: final clinical and pharmacologic data from a phase II protocol and recommended future directions. (2020) (8)
Cytoreductive surgery and intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy (2003) (8)
Unusually favorable outcome of 6 consecutive patients with diffuse malignant peritoneal mesothelioma treated with repeated doses of intraperitoneal paclitaxel. A case series. (2020) (8)
Comprehensive approach to advanced primary and recurrent ovarian cancer: a personal experience (2004) (8)
Right psoas muscle/aortoiliac groove recurrence: an unusual anatomic site for progression of epithelial tumors of the appendix. (2002) (8)
Pedunculated peritoneal surface polyps in pseudomyxoma peritonei syndrome (2001) (8)
Hepatic arterial infusion chemotherapy: rationale, results, credits and debits (1988) (8)
Cytoreductive Surgery Plus HIPEC With and Without NIPEC for Malignant Peritoneal Mesothelioma: A Propensity-Matched Analysis (2021) (8)
Gastric perforation following cytoreductive surgery with perioperative intraperitoneal chemotherapy (2010) (8)
Use of Saline-Filled Tissue Expanders to Protect the Small Bowel from Radiation (1998) (8)
Intraperitoneal paclitaxel: pharmacology, clinical results and future prospects. (2020) (8)
Comprehensive Management of Disseminated Colorectal Cancer (2008) (8)
A curative approach to malignant peritoneal mesothelioma. Case report and review of the literature (1991) (7)
Survey on the current gynaecological approach of ovarian cancer patients: The utility of HIPEC (2020) (7)
Extrahepatic tumor deposits misdiagnosed as intrahepatic metastases. (1988) (7)
Peritoneal Metastases (2012) (7)
Preoperative radiological evaluation of the liver by computerized tomographic portography in patients with hepatic tumors. (1992) (7)
Tailgut cyst, an unusual cause of pseudomyxoma peritonei. (2009) (7)
Intraperitoneal gemcitabine chemotherapy as an adjuvant treatment for patients with resected pancreatic cancer: Phase II and pharmacologic studies (2012) (7)
Surgical technique of hemipelvectomy in the lateral position. (1981) (7)
Management of recurrent granulosa cell tumor of the ovary: Contemporary literature review and a proposal of hyperthermic intraperitoneal chemotherapy as novel therapeutic option (2020) (7)
A cytoreductive approach to treatment of multiple liver metastases (1993) (7)
An Evolving Role of Perioperative Intraperitoneal Chemotherapy After Cytoreductive Surgery for Colorectal Peritoneal Carcinomatosis (2007) (7)
Peritoneal tunnels: A site at risk for treatment failure when performing treatments for peritoneal metastases. A case series of 2 patients (2019) (7)
Lymphokine-activated killer cell and interleukin-2 inhibitors: their role in adoptive immunotherapy. (1987) (7)
Management of pancreatitis due to pancreatic injury in cytoreductive surgery (1995) (7)
Prevention and Treatment of Peritoneal Metastases from Gastric Cancer (2021) (7)
The Seven Best from PSOGI 2016 (2017) (7)
Building on a consensus (2008) (7)
Decision-Making Analysis for Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: A Survey by the Executive Committee of the Peritoneal Surface Oncology Group International (PSOGI) (2020) (7)
Normothermic intraperitoneal chemotherapy long term (NIPEC-LT) in the management of peritoneal surface malignancy, an overview (2017) (7)
Progressive release of the left colon for a tension-free colorectal or coloanal anastomosis. (1996) (7)
Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus (2015) (7)
Challenging and unusual cases: Case 3. Peritoneal cystic mesothelioma. (2003) (6)
Twenty-three years of progress in the management of a rare disease. (2011) (6)
Prospective nonrandomized trial of silver impregnated cuff central lines. (2005) (6)
Abdominal and Pelvic Ct for Detection and Volume Assessment of Peritoneal Sarcomatosis (2002) (6)
Liver surgery for liver metastases. (1991) (6)
Cytoreduction and intraperitoneal chemotherapy for the management of non-gynecological peritoneal surface malignancy. (2003) (6)
A Prognostic Model for Predicting Overall Survival in Patients with Peritoneal Surface Malignancy of an Appendiceal Origin Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (2017) (6)
Peritoneal carcinomatosis of unknown primary site, a study of 25 patients over 30 years. (2020) (6)
Eradication of minimal residual disease in the perioperative period in primary colon cancer (2015) (6)
The management of recurrent colorectal cancer (1986) (6)
Port site recurrence, an unintended consequence of laparoscopic resection of ovarian cancer. A case report (2019) (6)
Long-term survival is possible using cytoreductive surgery plus HIPEC for sarcomatosis—Case report of 2 patients (2019) (6)
Inhibitory effects of alloimmune T cells on the generation of cytolytic responses of lymphokine-activated killer cells. (1987) (6)
Radiofrequency hyperthermia in the palliative treatment of mucinous carcinomatosis of appendiceal origin: optimizing and monitoring heat delivery in western patients (2000) (6)
Randomized controlled trial of early postoperative intraperitoneal chemotherapy in gastric cancer: a preliminary report (1994) (6)
Management of the surgically traumatized, irradiated, and infected pelvis. (1988) (6)
Lattice intrahepatic doxorubicin with and without in-flow occlusion: a pharmacokinetic study of direct liver injection. (2000) (6)
Radiolocalization of colon cancer with I-131 B72. 3 monoclonal antibody (1985) (6)
Overview of Peritoneal (2008) (6)
Binding of radiolabeled MAb B72.3 administered intravenously and intraperitoneally in colorectal cancer patients. An overview. (1990) (6)
Similar Survival Among All Subtypes of Mucinous Appendiceal Adenocarcinoma Except the Intermediate Subtype, Which Shows an Improved Survival (2022) (5)
Prevention of hernia after enterostomy. (1989) (5)
Pharmacology of chemotherapy treatments for peritoneal metastases: optimizing and augmenting HIPEC (2017) (5)
Laparoscopy in the diagnosis and treatment of peritoneal metastases (2019) (5)
Recurrent and advanced primary colorectal cancer: therapeutic implications of new concepts of gastrointestinal tumour biology. (1989) (5)
Advanced gastric cancer : review of regional chemotherapy trials and treatment strategy using stop-flow infusion (1995) (5)
Cytoreductive Surgery and Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies (2000) (5)
Characterization of in vivo suppression of syngenic tumor by allogenic effector cells (1980) (5)
SO14P PERIOPERATIVE OUTCOMES OF CYTOREDUCTIVE SURGERY AND PERIOPERATIVE INTRAPERITONEAL CHEMOTHERAPY FOR NON‐APPENDICEAL PERITONEAL CARCINOMATOSIS FROM A PROSPECTIVE DATABASE (2007) (5)
Interstitial pneumonitis following intrapleural chemotherapy (2009) (5)
From the guest editors: introduction: progress in the management of carcinomatosis. (2009) (5)
Peritonectomy for Peritoneal Carcinomatosis: Long-Term Outcomes from a Single Brazilian Institution (2009) (5)
Tenckhoff catheter administration of intraperitoneal fluid and electrolytes for long-term management of intractable ileostomy diarrhea: a case report. (1985) (5)
Synchronous primary neuroendocrine and mucinous epithelial tumors present in the same appendix. Case report of 2 patients (2020) (5)
Appendiceal tumors with glandular and neuroendocrine features exhibiting peritoneal metastases - Critical evaluation of outcome following cytoreductive surgery with perioperative chemotherapy. (2021) (5)
Surgical Therapy of Liver Cancer (1985) (5)
Diminished cellular cytotoxicity in mice hyperimmunized prior to skin grafting. (1981) (5)
[Treatment results of peritoneal dissemination from gastric cancer by neoadjuvant intraperitoneal-systemic chemotherapy]. (2004) (5)
Biological considerations with pelvic neoplasms (2000) (5)
SO03 CRITICAL ANALYSIS OF TREATMENT FAILURE FOLLOWING COMPLETE CYTOREDUCTIVE SURGERY AND PERIOPERATIVE INTRAPERITONEAL CHEMOTHERAPY FOR PERITONEAL DISSEMINATION FROM APPENDICEAL MUCINOUS NEOPLASMS (2007) (5)
Case report of combined surgical oncologic and bariatric procedures (2018) (5)
Avoiding carcinogen exposure with intraperitoneal paclitaxel. (2005) (5)
Intra-abdominal manifestations of pleural mesothelioma. (2017) (5)
Use of liposoluble contrast material to separate left renal and splenic parenchyma on computed tomography. (1980) (5)
Comprehensive treatment for the peritoneal metastasis from gastric cancer (2015) (5)
Peritoneal Metastases from Adrenal Cortical Carcinoma Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (2016) (5)
Erratum: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: A consensus statement (Annals of Surgical Oncology 14 (128-133)DOI: 10.1245/s10434-006-9185-7) (2011) (5)
Rectus abdominis muscle transplant for repair of abdominal wall defects required for cancer resections: Case report (2019) (5)
Treatment of advanced pseudomyxoma peritonei using cytoreductive surgery including total gastrectomy and perioperative chemotherapy (2021) (5)
Prognostic Implications of Chemoresistance‐Sensitivity Assays for Colorectal and Appendiceal Cancer (1995) (5)
The Chicago Consensus on peritoneal surface malignancies: Standards (2020) (4)
Malignant mesothelioma of the male genital tract (2001) (4)
Revised prognostic indicators for treatment of lymph node positive colorectal peritoneal metastases (2022) (4)
Pneumatic device for the automated advancement of the fiberoptic endoscope for total colonoscopy--a preliminary report. (1985) (4)
EVOLVING STRATEGIES FOR SURGICAL MANAGEMENT OF CARCINOMATOSIS (2006) (4)
Surgical management of metastatic cancer in the liver. (1996) (4)
In vivo generation of lymphokine activated killer cell activity by ABPP and interleukin-2 and their antitumor effects against immunogenic and nonimmunogenic tumors in murine tumor models (2004) (4)
Recurrent intraabdominal cancer causing intestinal obstruction: Washington Hospital Center experience with 42 patients managed by surgery and intraperitoneal chemotherapy. (1996) (4)
Use of the bladder as an abdominopelvic partition. (1989) (4)
Anatomic sites of disease in colorectal cancer patients recorded at the time of cytoreductive surgery for peritoneal metastases. (2022) (4)
Kocher maneuver to facilitate cytoreduction within the foramen of Winslow (2017) (4)
Rectus Abdominis Muscle Resection for Abdominal Wall Recurrence of Mucinous Adenocarcinoma or Peritoneal Mesothelioma (2008) (4)
Management of Abdominopelvic Sarcoma (2004) (4)
The Chicago Consensus on peritoneal surface malignancies: Management of desmoplastic small round cell tumor, breast, and gastrointestinal stromal tumors (2020) (4)
Adductor muscle group excision. (1982) (4)
Hepatic Arterial Infusion Chemotherapy: Clinical Trials with the Implantable Pump (1987) (4)
Advances in diffuse malignant peritoneal mesothelioma (2011) (4)
Cytoreductive Surgery and HIPEC in the Baltic States: An International Scientific Workshop with Live Surgery (2014) (4)
Adenocarcinoid of appendiceal origin causing peritoneal carcinomatosis (1994) (4)
Neomycin Toxicity from Porcine Skin Xenografts (1974) (4)
Femoral neuropathy (1998) (4)
Are there curative options to peritoneal carcinomatosis? Author's reply (2005) (4)
Troubleshooting a sump tube. (1993) (4)
Gastrointestinal decompression alter total gastrectomy using a side duodenostomy (1996) (4)
Total pelvic exenterative surgery in patients with peritoneal metastases from appendiceal neoplasms. A case series of 2 patients (2019) (4)
Liver metastasis. Report of a workshop, May 26th 1984. (1986) (4)
Synergistic antitumor activity of cyclophosphamide and ABPP in the treatment of established and advanced tumors in murine tumor models (2004) (4)
Recurrence of Pseudomyxoma Peritonei within the Inguinal Canal (2005) (4)
The Characteristics of 206 Long-Term Survivors with Peritoneal Metastases from Colorectal Cancer Treated with Curative Intent Surgery: A Multi-Center Cohort from PSOGI (2021) (4)
Peritoneal carcinomatosis of unknown primary site may be an undiagnosed appendiceal adenocarcinoma. A case series (2019) (4)
Management of peritoneal surface malignancy: a short history. (2007) (4)
Surgery for Recurrent Colon Cancer (1999) (3)
A surgical technique for buttockectomy. (1982) (3)
Clinical Research to Standard of Care: When Does the Transition Occur? (2003) (3)
Safety constiderations in the use of intraoperative intraperitoneal chemotherapy. (1996) (3)
Peritoneal metastases from malignant degeneration of ectopic gastric epithelium in Meckel’s diverticulum: A case report (2019) (3)
Technical aspects of adjuvant intraperitoneal chemotherapy (1991) (3)
Technical aspects and morbidity assessment of intraperitoneal chemotherapy administered by repeated paracentesis (1992) (3)
Early antigen elimination by cytotoxic T cells results in diminished cellular immune responses to allogeneic tumor. (1981) (3)
Recruitment of inflammatory cells to a tumor deposit potentiates the immunotherapeutic effects of interleukin-2 (2004) (3)
Avoiding a throwback to the past. (2013) (3)
Home parenteral nutrition for patients with advanced intraperitoneal cancers and gastrointestinal dysfunction. (1987) (3)
Cytotoxic cells suppress in vitro generation of cellular immunity by stimulator cell lysis. (1981) (3)
Neoadjuvant chemotherapy in epithelial ovarian cancer (2017) (3)
[The role of intraperitoneal chemotherapy after curative excision of primary abdominopelvic sarcoma]. (1998) (3)
False-positive lymph nodes by radioimmunoguided surgery: report of a patient and analysis of the problem. (1993) (3)
Pharmacology and therapeutics in gynecologic cancer (2013) (3)
Intraperitoneal doxorubicin achieves access to mesenteric lymph nodes, case series of two patients☆ (2018) (3)
A matrix for controlled clinical trials for the study of hepatic metastases: Proceedings of a workshop (1986) (3)
Biodistribution of monoclonal antibody B72. 3(I-131) in colon cancer patients (1985) (3)
Management of Truncal Sarcoma (2004) (3)
A monoclonal antibody (B72.3) to adenocarcinoma of the colon and related tumors. (1989) (3)
Hepatic Resection Using Ultrasonic Fragmentation. (1991) (3)
Revised clinical pathway for the management of peritoneal metastases from colorectal cancer using NCCN 2017 guidelines (2017) (3)
The PRODIGE 7 randomized trial has 4 design flaws and 4 pharmacologic flaws and cannot be used to discredit other HIPEC regimens. (2021) (3)
Tailgut Cyst, an Unusual Cause of Pseudomyxoma Peritonei (2009) (3)
Oligometastatic Disease in the Peritoneal Space with Gastrointestinal Cancer (2017) (3)
After thirty years of experience with early postoperative intraperitoneal 5-fluorouracil now saying goodbye. (2022) (3)
Adjuvant HIPEC for gastric cancer. (2021) (3)
Intraperitoneal 5-FU in Patients with Colon or Rectal Cancer (1988) (3)
Lessons in comparative oncology. (1991) (3)
HIPEC plus EPIC paclitaxel for maximal perioperative treatments of advanced epithelial ovarian cancer. Long-term results of a pilot study. (2020) (3)
Pharmacology of cancer chemotherapy drugs for hyperthermic intraperitoneal peroperative chemotherapy in epithelial ovarian cancer (2013) (3)
Adjuvant intraperitoneal chemotherapy: a review. (2007) (3)
Perioperative FOLFOX in management of peritoneal metastases of colorectal cancer. Case report of 2 patients (2020) (3)
Excision of quadriceps muscle group. (1983) (3)
Screening and early diagnosis of colorectal cancer (1987) (3)
Long-term survival in patients with peritoneal metastasized gastric cancer treated with cytoreductive surgery and HIPEC: A multi-institutional cohort from PSOGI. (2020) (3)
Ovarian metastases from right colon cancer treated with systemic cancer chemotherapy, a case report (2018) (3)
Secondary cytoreductive surgery for low‐grade appendiceal mucinous neoplasms (2022) (3)
Psoas/iliacus muscle invasion from mucinous appendiceal neoplasm. Radiologic appearance and outcome of treatment in 3 patients. (2018) (3)
Effects of passive enhancement on graft and host. Graft adaptation by alloantibody as the mechanism of prolonged skin allograft survival. (1984) (3)
How safe and effective is surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei? (2007) (3)
Immunogenicity of the tumor determines the outcome of immunotherapy with interleukin-2, ABPP, and cyclophosphamide of micro- and macrometastatic intraperitoneal tumor. (1990) (3)
The National Institutes of Health Experience with Radiolabeled Monoclonal Antibodies: Lymphoma, Melanoma, and Colon Cancer (1988) (3)
Pseudomyxoma peritonei: first cases treated by radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (2009) (3)
Prospective Registry On Mesothelioma Peritonei Treatment (PROMPT): study design and rationale. (2012) (3)
The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations (2020) (3)
Peritoneal Metastases: Prevention and Treatment (2016) (3)
Surgery, Hyperthermic Chemoperfusion, and Postoperative Chemotherapy: The National Cancer Institute and Washington Hospital Center Experience (2005) (3)
Reported Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Systemic Toxicity (2008) (3)
Surgical Therapy of Hepatic Metastases (1984) (3)
Liver Resection for Colorectal Secondaries (1992) (2)
Central venous access through the right gonadal vein (2002) (2)
Resection of the Posterior Compartment of the Thigh (2004) (2)
Comprehensive management of resectable gastric cancer: requirement for optimal clearance, containment and perioperative intraperitoneal chemotherapy (2000) (2)
Rationale for perioperative chemotherapy treatment in peritoneal carcinomatosis (2009) (2)
Lymph node positive pseudomyxoma peritonei. (2022) (2)
Local-regional approach to diffuse malignant peritoneal mesothelioma. (2007) (2)
ENHANCING ALLOANTIBODY EFFECTIVE DURING SENSITIZATION BUT NOT EFFECTOR PHASE OF SKIN GRAFT REJECTION (1979) (2)
Peritoneal metastases invading the seminal vesicles: Radiologic appearance and outcome of treatment. (2018) (2)
Diagnosis and Management of Epithelial Ovarian Cancer with Peritoneal Metastases (2014) (2)
Vertical abdominoplasty (2001) (2)
Peritoneal cytology as an indicator of peritoneal metastases in colorectal cancer (2021) (2)
Alloantigen-activated lysis of syngenic tumor augmented by allogenic lymphocytes as cold targets. (1985) (2)
The Chicago Consensus Guidelines for Peritoneal Surface Malignancies: Introduction (2020) (2)
Selection Factors for Treatment and Stratification of Rare Abdominal or Pelvic Tumors with Peritoneal Metastases (2022) (2)
Above-knee Amputation (2004) (2)
Radiofrequency Hyperthermia Alone in the Palliative Treatment of Mucinous Carcinomatosis: Optimizing and Monitoring Heat Delivery (2001) (2)
ASO Author Reflections: Similar Survival of All Subtypes of Mucinous Appendiceal Adenocarcinoma Except the Intermediate Subtype Which Shows an Improved Survival (2022) (2)
Splenic metastases – hematogenous disease or invasive peritoneal implants? Case reports of two patients (2020) (2)
Symposium: The management of recurrent colorectal cancer. (1986) (2)
Abrogation of T cell homing by alloantibody: A new mechanism of immunological enhancement (1980) (2)
A Patent Cranial End of the Ductus Venosus Can Result in Hemorrhage when Performing a Lesser Omentectomy–Omental Bursectomy Procedure (2016) (2)
Optimizing regional chemotherapy for epithelial ovarian cancer (2022) (2)
Anatomic localization and step by step advancement of the fiberoptic colonoscope. (1976) (2)
Quadriceps Muscle Group Excision (2004) (2)
Local-Regional Adoptive Immunotherapy in Experimental Peritoneal Carcinomatosis Using Lymphokine Activated Killer Cells and Interleukin-2 (1988) (2)
Management of Gastric Cancer (2012) (2)
The rule of least margins : rationale for surgical treatment planning in gastrointestinal cancer (1991) (2)
Cytoreductive approach to treatment of multiple liver metastases. (1994) (2)
Management of patients with advanced ovarian cancer – Role of complete cytoreduction and HIPEC: Attitudes of gynaecologist oncologists in two different continents (2021) (2)
Retransplantation of murine skin allografts: assessment of treatment effects on the allograft in the absence of effects on the host. (1984) (2)
Cytoreductive surgery and intraperitoneal chemotherapy. Treatment for peritoneal carcinomatosis. (1992) (2)
Concepts in the delivery of monoclonal antibodies in the targeting of human carcinomas (1988) (2)
Treatment of pseudomyxoma peritonei in a geriatric patient population (1995) (2)
Thrombocytopenia from metastatic carcinoma of the breast. Effective managements of patients with this complication. (1973) (2)
Unusual radiologic presentations of malignant peritoneal mesothelioma (2020) (2)
Acute abdomen caused by a large solitary jejunal diverticulum that induced a midgut volvulus. Report of a case (2020) (2)
Management of peritoneal surface malignancy. Preface. (2003) (2)
Extent of Disease on Visceral Peritoneal Surfaces of Mucinous Appendiceal Neoplasms Controls Survival (2022) (2)
Clinical determinants of treatment failures after cytoreductive surgery and intraperitoneal chemotherapy in patients with pseudomyxoma peritonei (1995) (2)
Peritoneal metastases from colorectal cancer in the absence of lymph node metastases show a high survival rate despite unfavorable prognostic indicators. (2022) (2)
Host modification on the skin allograft assay. (1982) (2)
HP40P A SYSTEMATIC REVIEW AND META‐ANALYSIS OF THE RANDOMISED CONTROLLED TRIALS ON ADJUVANT INTRAPERITONEAL CHEMOTHERAPY FOR ADVANCED GASTRIC CANCER (2007) (2)
Malignant peritoneal mesothelioma presenting as a mass in a Spigelian hernia. Report of a case (2020) (2)
Intraperitoneal Adoptive Immunotherapy Using Lymphokine-Activated Killer Cells and Interleukin-2 (1988) (1)
Ovarian cancer with peritoneal metastases has many treatment options and HIPEC is here to stay. (2021) (1)
Diverting transverse colostomy in a midline incision, a case report (2019) (1)
PIPAC may work but more data is needed. (2021) (1)
Decreasing the Risk of a Treatment Expands Its Indications (2005) (1)
Coordinating cancer care using a weekly patient‐oriented conference (1988) (1)
The Treatment of Soft‐tissue Sarcomas of the Extremities: Prospective Randomized Evaluations of (1) Limb-sparing surgery Plus Radiation Therapy Compared with Compared with amputation and (2) the Role of adjuvant Chemotherapy (1982) (1)
C o m p r e h e n s i v e management of resectable gastric cancer: requirement for optimal clearance, containment and perioperative intraperitoneal c h e m o t h e r a p y (2000) (1)
Neoadjuvant, adjuvant and long-term intravenous/intraperitoneal chemotherapy, hyperthermic intraperitoneal chemotherapy, early postoperative intraperitoneal chemotherapy for ovarian cancer (2017) (1)
Laparoscopy technique in the setting of peritoneal metastases to avoid port site relapse. (2021) (1)
Hepatic Resection for Colorectal Carcinoma Metastases: Present Status and Future Prospects (1986) (1)
Evaluation of clonal origin of malignant mesothelioma (2014) (1)
PROLOGED SKIN ALLOGRAFT SURVIVAL THORUGH ENHANCEMENT EFFECTS ON DONOR TISSUE (1986) (1)
Colorectal Cancer - Management of Metastatic Disease (2013) (1)
Interview: The evolution of treatment for peritoneal metastases (2013) (1)
19 Anterior Flap Hemipelvectomy (2001) (1)
A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for advanced gastric cancer (2007) (1)
Chapter-02 Pseudomyxoma Peritonei and Peritoneal Mucinous Carcinoma of Appendiceal Origin (2012) (1)
22 Above-knee Amputation (2001) (1)
7 Management of Abdominopelvic Sarcoma (2001) (1)
Chronic perineal fistula as a late failure manifestation of pseudomyxoma peritonei syndrome (2004) (1)
Rendezvous procedure to establish ureteral continuity from a delayed ureteral leak following pelvic surgery. A case report (2020) (1)
Reply to the Letter From Dr Singhal et al. (2016) (1)
Treatment of Pseudomyxoma Peritonei from Non-appendiceal Primary Sites (2017) (1)
Clinical and Histopathologic Features of 35 Patients Treated for Colorectal Peritoneal Metastases Who Survived 5 Years. (2023) (1)
Measurements of human anti murine antibodies in patients who received radiolabeled monoclonal antibodies (1986) (1)
Getting Chemotherapy into the Cancerous Tissue (2008) (1)
Quality of Life and Cost Effectiveness Issues in the Management of Patients with Hepatic Metastases from Colorectal Cancer (1986) (1)
Dr Nelson and colleagues respond (1991) (1)
Incomplete cytoreduction with peritoneal metastases from appendiceal mucinous neoplasms (2022) (1)
Prevention and Management of Peritoneal Metastases from Gastrointestinal Cancer: A Short History of a Paradigm for Peritoneal Surface Malignancies (2015) (1)
Computed tomography in peritoneal surface malignancy (2008) (1)
Long-term outcomes after cytoreductive surgery and HIPEC for morcellated uterine leiomyosarcoma; A case series (2021) (1)
Peritoneal Surface Oncology Group International (PSOGI) multicenter study on nomograms to predict overall survival in diffuse malignant peritoneal mesothelioma. (2018) (1)
Increased Safety of Surgical Glove Application: The Under/Over Method (2018) (1)
Clinical pathway for the management of gastric cancer with peritoneal seeding (1999) (1)
Effects on syngeneic tumors of F1 lymphocytes sensitized in vitro by parental stimulator cells. (1985) (1)
Adenocarcinoma as a Cause of Acute Appendicitis (2017) (1)
Endoscopy in cancer diagnosis and management. (1984) (1)
Theoretical Considerations for Optimal Cytoreductive Surgery Plus Hyperthermic Perioperative Chemotherapy (2015) (1)
Optimization of Patient Selection for Surgical Approach to Peritoneal Metastases from Gastrointestinal Cancer Using Cytoreductive Surgery and Perioperative Chemotherapy (2014) (1)
Two methodologies of the rendezvous procedure to establish ureteral continuity from a delayed ureteral leak following pelvic surgery (2022) (1)
Activated killer monocytes: use in clinical trials. (1989) (1)
Analysis of Histologic Parameters Associated with Nuclear Size in Diffuse Malignant Peritoneal Mesothelioma Uniformly Treated by Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy (2013) (1)
Local-Regional Approach to Peritoneal Carcinomatosis Combining Cytoreductive Surgery with Adoptive Immunotherapy Utilizing Gamma Interferon Activated Autologus Monocytes (1988) (1)
Incomplete Cytoreduction of Colorectal Cancer Peritoneal Metastases: Survival Outcomes by a Cytoreduction Score (2022) (1)
Sacral resection in cancer surgery. (2004) (1)
Revised management of advanced primary colon cancer: Case series of 2 patients (2019) (1)
Effect of long-term intraperitoneal chemotherapy for patients with malignant peritoneal mesothelioma on survival. (2015) (1)
Hepatic parenchymal suction dissector. (1986) (1)
In vitro and in vivo models for monitoring the adoptive immunotherapeutic effects of recombinant gamma-interferon-activated human monocytes. (1987) (1)
The Chicago Consensus on peritoneal surface malignancies: Management of neuroendocrine tumors (2020) (1)
Liver resection for colorectal metastases: who, when, and to what extent? (1988) (1)
Is there an oncological interest in the combination of CRS / HIPEC for peritoneal carcinomatosis of HCC? Results of a Multicenter International Study (2018) (1)
Eliminating tumor cell entrapment from the natural history of ovarian cancer, a narrative summary (2021) (1)
Peritoneal metastases and peritoneal mesothelioma (2015) (1)
Commentary (0)
Twenty-year survival of gastric cancer with peritoneal metastases using long-term normothermic intraperitoneal 5-fluorouracil and systemic mitomycin C: A case report (2019) (0)
Observations on opening and closing the abdominal incision for cytoreductive surgery using a self-retaining retractor to reduce the incidence of incisional hernia. (2020) (0)
Abrogation of T cell homing by alloantibody. (1980) (0)
Induction Bidirectional Chemotherapy for Gastric Cancer with Peritoneal Dissemination (2011) (0)
Pathogenesis of histologic variations of appendiceal mucinous neoplasms. (2023) (0)
44 Comprehensive management of gastrointestinal cancer: Focus on appendiceal mucinous neoplasms, primary gastric cancer and gastric cancer with peritoneal seeding (2009) (0)
Aggressive local treatments may prolong survival but do not have curative intent. (2021) (0)
Evolution for survival. (1991) (0)
Palliation of mucinous appendiceal neoplasms with peritoneal metastases with total abdominal colectomy (2023) (0)
Coordinating Cancer Care Using a Weekly Patient-Oriented Conference (1988) (0)
Cytoreduction including total gastrectomy for pseudomyxoma peritonei. Author's reply (2002) (0)
Prevention and treatment of carcinomatosis from colorectal malignancy (1999) (0)
Ultrasonic dissection for pseudomyxoma peritonei: Debulking, not cytoreduction (2000) (0)
Book ReviewColonoscopy: Diagnosis and treatment of colonic diseases (1982) (0)
Toxicity of a Uniform Combined Bidirectional Hyperthermic and Perioperative Intraperitoneal Chemotherapy Regimen after Cytoreductive Surgery in 147 Peritoneal Surface Malignancy Patients (2010) (0)
Pharmacology of intraperitoneal chemotherapy for gastrointestinal cancer and diffuse malignant peritoneal mesothelioma (2006) (0)
SO13P CYTOREDUCTIVE SURGERY COMBINED WITH PERIOPERATIVE INTRAPERITONEAL CHEMOTHERAPY FOR DIFFUSE MALIGNANT PERITONEAL MESOTHELIOMA – ANALYSIS OF 100 CONSECUTIVE PATIENTS FROM A PROSPECTIVE DATABASE (2007) (0)
Knowledgeable case selection results in favorable outcomes. (2021) (0)
17 Forequarter Amputation (2001) (0)
Surgical and chemotherapeutic cytoreduction for advanced primary and recurrent ovarian cancer , the Washington Cancer Institute approach (2010) (0)
Invited editorial (2000) (0)
199. Natural Killer and Lymphokine Activated Killer Cytotoxicity of Human Peripheral Blood Lymphocytes Against Human Colorectal Cancer Cell Lines (1988) (0)
Visceral and retroperitoneal sarcomas: clinical presentation and therapeutic options (2003) (0)
Above-elbow and Below-elbow Amputations (2004) (0)
Comprehensive management of epithelial ovarian cancer with peritoneal metastases (2013) (0)
Immunologic paralysis induced by alloantiserum. Abstr. (1982) (0)
Adjuvant Applications of Infusional Chemotherapy (1987) (0)
Technique of Hepatic Infusion Chemotherapy (1984) (0)
Atlas of Enteroscopy (1977) (0)
Continuing Progress in the Interdisciplinary Management of Peritoneal Metastases (2022) (0)
117 Critical analysis of nuclear size as an assessment of prognosis in diffuse malignant peritoneal mesothelioma (2006) (0)
Book ReviewFollow-Up of the Cancer Patient (1983) (0)
Cashin and Graf: long-term intraperitoneal 5-fluorouracil is superior to adjuvant FOLFOX in a randomized trial. (2021) (0)
Surgical Management of Peritoneal Surface Spread of Colorectal Cancer (2002) (0)
Malignant peritoneal mesothelioma: a narrative review of the rationale for and results of treatment using ultraradical local-regional strategy (2021) (0)
Survival of large volume recurrent endometrial cancer with peritoneal metastases treated by cytoreductive surgery, HIPEC and EPIC. Report of a case (2021) (0)
Progression of perforated cystadenoma of the appendix to pseudomyxoma peritonei over 18 years. A case report (2022) (0)
Exteriorized small bowel as an abdomino‐pelvic partition (2002) (0)
Restoration of mlc responsiveness by soluble factors. Abstr. (1983) (0)
A proposed staging system for diffuse malignant peritoneal mesothelioma patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy. (2006) (0)
Second Hepatic Resections in Patients with Liver Metastases from Colorectal Carcinoma (1990) (0)
Surgical responsibilities in metastases predominant vs. spread predominant cancers (1999) (0)
Paclitaxel is the pharmacologic near perfect chemotherapy for peritoneal metastases. (2021) (0)
27 Sacrectomy Constantine Karakousis and Paul Sugarbaker OVERVIEW Sacrectomy (2001) (0)
Single institution best recommendation is HIPEC with cisplatin and docetaxel. (2021) (0)
Drug combinations for hipec after cytoreductive surgery in diffuse malignant peritoneal mesothelioma: A PSOGI registry study (2018) (0)
review Current treatment options and biology of peritoneal mesothelioma: meeting summary of the ﬁrst NIH peritoneal mesothelioma conference (2006) (0)
Book ReviewPractical Fiberoptic Colonoscopy (1981) (0)
SURGERY FOR RECURRENT COLON CANCER. AUTHORS' REPLY (1999) (0)
Development of drug resistance in colon cancer patients following chemotherapy, a contributing factor in the failure of oxaliplatin-based HIPEC to improve survival in the Prodige 7 trial. (2020) (0)
Xenogeneic cellular immune responses and the control of microscopic tumor. A model. (1982) (0)
Abstract 3188: Evaluation of clonal origin of malignant mesothelioma/polyclonal origin of malignant mesothelioma (2014) (0)
Super-responders to bidirectional neoadjuvant chemotherapy showed prolonged survival. (2021) (0)
Gr upSM Regional Chemotherapy : Possibilities for Prevention and Treatment of Peritoneal Metastases from Gastric Cancer (2016) (0)
Pseudomyxoma peritonei and appendiceal carcinoma with peritoneal metastases: current management strategies (2018) (0)
Nomograms to predict prognosis in pseudomyxoma peritonei: a Peritoneal Surface Oncology Group International (PSOGI) multicenter study (2014) (0)
128 Staging of peritoneal mesothelioma (2006) (0)
Ultrasonic Surgery in Oncology (1995) (0)
Conference Scene: Second Annual Workshop of the Mid-Atlantic Chapter of the American Society of Peritoneal Surface Malignancy (2013) (0)
Management of Appendiceal Malignancy. (2019) (0)
Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: An Ongoing Research Effort (2010) (0)
Efficacy of intracavitary administration of cyclophosphamide, interleukin-2 and lymphokine activated killer cells against established intraperitoneal tumor. (1989) (0)
Cytoreductive Surgery for Advanced Colon Cancer (2020) (0)
Management of peritoneal metastases using cytoreductive surgery and perioperative chemotherapy (2015) (0)
[The results of surgical treatment for pseudomyxoma peritonei]. (2006) (0)
IL6 TREATMENT OF PERITONEAL SURFACE MALIGNANCY, CARCINOMATOSIS, SARCOMATOSIS, AND MESOTHELIOMA (1999) (0)
Surgical treatment of pseudomyxoma peritonei (1991) (0)
Contents, Vol. 42, 1985 (1985) (0)
Duodenectomy with jejunal advancement and reimplantation of the ampulla of Vater for recurrent right colon cancer: A case report (2019) (0)
Staging of patients with suspected isolated colorectal liver metastases. (1987) (0)
In Reply. (2016) (0)
Regional Therapy for Peritoneal Surface Malignancy (2007) (0)
Historical Perspective for Regional Peritoneal Therapy: HIPEC, EPIC, and Port-Based Therapy (2019) (0)
Secondary cytoreductive surgery for lymph node positive mucinous appendiceal neoplasms. (2023) (0)
Chemoresistance can limit the success of radical surgery followed by early postoperative intraperitoneal chemotherapy in gastric carcinoma (reply) (2000) (0)
Is Repeated Hepatic Resection Justified for Malignancy? (1991) (0)
Optimizing peritoneoscopic visualization of the liver utilizing a double telescope technique. (1981) (0)
Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy for Colorectal Cancer: A New Standard of Care (2005) (0)
Techniques of Hepatic Surgery for Metastatic Cancer (1984) (0)
Title Page / Table of Contents / Imprint / Guidelines for Authors (2014) (0)
Current data is sufficient to recommend a current standard of care. (2021) (0)
Diagnosis and management of colorectal cancer. (1987) (0)
Long-term outcomes after cytoreductive surgery and hyperthermic perioperative chemotherapy for morcellated uterine leiomyosarcoma: case series (2021) (0)
A model for accurate histopathologic assessment refines treatment options. (2021) (0)
Commentary (2001) (0)
Administered Intraperitoneally to Patients with Ovarian Cancer Phase I and Pharmacological Studies of Adriamycin (2006) (0)
The Infusaid Pump and Hepatic Regional Chemotherapy (1984) (0)
Gross and Histologic Types of Mucinous Appendiceal Neoplasms (2009) (0)
Author's reply (2002) (0)
Suppression of murine immunologic functions by fresh and cultured human tumor extracts. (1985) (0)
Prospective Registry on Mesothelioma Peritonei Treatment (PROMPT): Study Design and Rationale (2012) (0)
Letters to the Editor (2003) (0)
CHARACTERISTICS OF COLORECTAL CARCINOMA CELL LINES paraffin embedded sections of xenografts (2006) (0)
Total abdominal colectomy to facilitate complete cytoreduction in 56 patients with mucinous appendiceal neoplasms with peritoneal metastases (2023) (0)
Neoplastic Appendicitis (2016) (0)
THE NATIONAL INSTITUTES OF HEALTH EXPERIENCE WITH RADIO- LABELED MONOCLONAL ANTIBODIES: LYMPHOMA, MELANOMA, AND COLON CANCER (0)
IS-1-1 Carcinomatosis can be cured(IS-1 International consensus of the treatment strategy for peritoneal malignancy) (2011) (0)
Paraostomy Hernias: Prevention and Prosthetic Mesh Repair (2001) (0)
Zang RY, Zhang ZY, Li ZT et al. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer. Eur J Surg Oncol 2000; 26:798-804. (2001) (0)
Lysis of syngeneic tumor by alloantigen activated t cells is augmented by the relevant alloantigen added as a cold target to cml assays. Abstr. (1982) (0)
Pleurectomy and decortication are associated with better survival for bicavitary cytoreductive surgery for mesothelioma compared with extrapleural pneumonectomy. (2022) (0)
“Total Mesenteric Peritonectomy for Peritoneal Metastases” (with Video) by Jean-Baptiste Cazauran et al. (2017) (0)
Increased safety of surgical glove application: the under/over method. (2018) (0)
Peritonectomy of the colonic mesentery. Case report of a new surgical technology (2021) (0)
The options are neoadjuvant, adjuvant, or no chemotherapy at all: further data is needed. (2021) (0)
Reply to M. Markman (2010) (0)
Constricting lesions of the large bowel. (1984) (0)
6.5 Adjuvante Therapie (1990) (0)
Adoptive transfer of cells sensitized in vitro into mice in a skin allograft assay. (1982) (0)
Snare polypectomy with the fiberoptic colonoscope. (1974) (0)
129. Technical aspects of hyperthermic perioperative chemotherapy (2012) (0)
A New Comprehensive Treatment for Peritoneal Metastases Using Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemoperfusion (2016) (0)
Prognostic Value of Early Postoperative Intraperitoneal Chemotherapy in Resectable Advanced Gastric Cancer (2001) (0)
The winn assay as a model of local immuno therapy characterization of in vivo suppression of syngeneic tumor by allogeneic effector cells (1979) (0)
Incidental Finding of Benign Multicystic Peritoneal Mesothelioma: A Case Report (2016) (0)
EP872 Ovarian cancer and HIPEC: survey for causes, symptoms and treatment multidisciplinary approach – the gynae-oncologists perspective (2019) (0)
MANAGEMENT PERSPECTIVE (2012) (0)
Integration of Cytoreductive Surgery and Perioperative Chemotherapy into the Multidisciplinary Management of Intra-Abdominal Cancer (2022) (0)
Cytoreductive Surgery and Intraperitoneal Chemotherapy for Treatment of Malignant Peritoneal Mesothelioma (2019) (0)
Learning curve and surgical performance of cytoreductive surgery and intraperitoneal chemotherapy for Pseudomyxoma peritonei: a PSOGI multicentric study (2013) (0)
Protocols versus practice in the management of colorectal peritoneal metastases (2022) (0)
21 September 2012: 14:30 – 16:00 Symposium: Regional therapy205. The influence of sound pharmacologic studies in hyperthermic perioperative chemotherapy – Development and practice for peritoneal metastases from gastrointestinal and ovarian cancer (2012) (0)
ASO Author Reflections: Normothermic Intraperitoneal Chemotherapy Long-Term for Malignant Peritoneal Mesothelioma (2021) (0)
Multimodality Therapy for Peritoneal Dissemination (1999) (0)
Peritoneal progression after pancreaticoduodenectomy is a devastating surgical treatment failure: HIPEC gemcitabine is an option. (2021) (0)
Management of malignancy-associated bowel obstruction by cervical esophagostomy and total parenteral nutrition, case series of 2 patients (2018) (0)
Third look surgery and beyond for appendiceal malignancy with peritoneal dissemination: Commentary (2003) (0)
Improved response of hyperthermic vs normothermic mitomycin C intraperitoneal chemotherapy for adenocarcimona : report of a case (1995) (0)
New Indications and New Reoperative Surgical Technologies for Second Lok Surgery in Colorectal Cancer (2010) (0)
115 A systematic review on the efficacy of cytoreductive surgery combined with perioperative chemotherapy for diffuse malignant peritoneal mesothelioma: An evolution of treatment strategies (2006) (0)
Invited editorial (1999) (0)
Erratum to: Five Reasons Why Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Must be Regarded as the New Standard of Care for Diffuse Malignant Peritoneal Mesothelioma (2011) (0)
Fate of 7-Interferon-activated Killer Blood Monocytes Adoptively Transferred into the Abdominal Cavity of Patients with Peritoneal Carcinomatosi* (2006) (0)
Intraperitoneal chemotherapy for treatment of peritoneal surface malignancy (1998) (0)
CHAPTER 63 – CANCER OF THE APPENDIX AND PSEUDOMYXOMA PERITONEI SYNDROME (2005) (0)
243. The pharmacokinetic rationale for the use of immediate postoperative intraperitoneal chemotherapy in patients with gastrointestinal malignancy (1988) (0)
Prevention of hemorrhage by elastic suture material used for securing intravenous catheters within major branches of the portal vein. (1988) (0)
Hybrid ileostomy (2006) (0)
Secondary cytoreductive surgery for 86 patients with mucinous appendiceal adenocarcinoma (2023) (0)
Book ReviewGastrointestinal Surgery (1985) (0)
Genetic targets for cancer control are a reality. (2021) (0)
Sarcomas Involving the Head and Neck, Trunk and Breast (1994) (0)
Intraperitoneal chemotherapy for peritoneal metastases: confronting diversity, maximizing benefit. (2021) (0)

This paper list is powered by the following services:

Other Resources About Paul Sugarbaker

en.wikipedia.org

What Schools Are Affiliated With Paul Sugarbaker?

Paul Sugarbaker is affiliated with the following schools: